Aristo Pharmaceuticals Private Limited — Ambroxol Exporter Profile
Indian Pharmaceutical Exporter · #9 for Ambroxol · $320.1K export value · DGFT Verified
Aristo Pharmaceuticals Private Limited is the #9 Indian exporter of Ambroxol with $320.1K in export value and 116 verified shipments. Aristo Pharmaceuticals Private Limited holds a 2.2% market share in Ambroxol exports across 6 countries. The company exports 8 pharmaceutical products worth $19.4M across 8 therapeutic categories.
Aristo Pharmaceuticals Private Limited — Ambroxol Export Profile: Buyers & Destinations
Where Does Aristo Pharmaceuticals Private Limited Export Ambroxol?
| Country | Value | Shipments | Share |
|---|---|---|---|
| TANZANIA | $144.6K | 21 | 45.2% |
| KENYA | $94.6K | 32 | 29.6% |
| MALDIVES | $39.7K | 56 | 12.4% |
| UGANDA | $39.2K | 4 | 12.2% |
| MYANMAR | $1.5K | 1 | 0.5% |
| CAMBODIA | $522 | 2 | 0.2% |
Aristo Pharmaceuticals Private Limited exports Ambroxol to 6 countries. The largest destination is TANZANIA accounting for 45.2% of Aristo Pharmaceuticals Private Limited's Ambroxol shipments, followed by KENYA (29.6%) and MALDIVES (12.4%). These destinations reflect Aristo Pharmaceuticals Private Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Ambroxol from Aristo Pharmaceuticals Private Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| NORVIK ENTERPRISES LIMITED | KENYA | $124.2K | 16 |
| PLANET PHARMACEUTICAL LTD, | TANZANIA | $117.3K | 17 |
| ADK PHARMACEUTICAL COMPANY PVT LTD | MALDIVES | $35.4K | 43 |
| PLANET PHARMACEUTICAL LTD | TANZANIA | $27.3K | 4 |
| SURGILINKS LIMITED | KENYA | $9.6K | 20 |
| ADK PHARMACEUTICAL COMPANY PRIVATE LIMITED | MALDIVES | $2.7K | 5 |
| JMS COMPANY LIMITED | MYANMAR | $1.5K | 1 |
| ADK PHARMACEUTICAL COMPANY PVT LTD, | MALDIVES | $1.4K | 2 |
| IDEAL TRADING | CAMBODIA | $522 | 2 |
| ADK PHARMACEUTICAL COMPANY PVT LTD. | MALDIVES | $221 | 6 |
Aristo Pharmaceuticals Private Limited supplies Ambroxol to 10 buyers globally. The largest buyer is NORVIK ENTERPRISES LIMITED (KENYA), followed by PLANET PHARMACEUTICAL LTD, (TANZANIA) and ADK PHARMACEUTICAL COMPANY PVT LTD (MALDIVES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Ambroxol Export Value and How Much Does Aristo Pharmaceuticals Private Limited Contribute?
India exported $7.8M worth of Ambroxol through 1,705 shipments from 296 suppliers to 92 countries, serving 486 buyers globally. Aristo Pharmaceuticals Private Limited contributes $320.1K to this total, accounting for 2.2% of India's Ambroxol exports. Aristo Pharmaceuticals Private Limited ships Ambroxol to 6 countries through 10 buyers.
What Is the Average Shipment Value for Aristo Pharmaceuticals Private Limited's Ambroxol Exports?
Aristo Pharmaceuticals Private Limited's average Ambroxol shipment value is $2.8K per consignment, based on 116 shipments totaling $320.1K. The largest destination is TANZANIA (45.2% of Aristo Pharmaceuticals Private Limited's Ambroxol exports).
How Does Aristo Pharmaceuticals Private Limited Compare to Other Indian Ambroxol Exporters?
Aristo Pharmaceuticals Private Limited ranks #9 among 296 Indian Ambroxol exporters with a 2.2% market share. The top 3 exporters are WEXFORD LABORATORIES PRIVATE LIMITED ($1.4M), BIOMATRIX HEALTHCARE PRIVATE LIMITED ($1.1M), FOURRTS (INDIA) LABORATORIES PRIVATE LIMITED ($958.0K). Aristo Pharmaceuticals Private Limited processed 116 shipments to 6 destination countries.
What Ambroxol Formulations Does Aristo Pharmaceuticals Private Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| HARMLESS MEDICINES- AMBRODIL SYRUP, AMBROXOL HYDROCHLORIDE SYRUP 30MG Batch No.EMPC241267 (50000X100 ML)Mfg.Dt. 03/2024 | $46.6K | 2 |
| HARMLESS MEDICINES Ambrodil Drops AMBROXOL HYDROCHLORIDE DROPS BatchNo EMPC250885 Mfg Date 03 2025 Exp Da | $18.5K | 1 |
| HARMLESS MEDICINES Ambrodil Syrup AMBROXOL HYDROCHLORIDE SYRUP 30MG Batch No EMPC251090 Mfg Date 03 2025 Ex | $17.1K | 1 |
| AMBRODIL SYRUP (40000X100ML) AMBROXOL HY | $17.1K | 1 |
| HARMLESS MEDICINES- AMBRODIL DROPS AMBROXOL HYDROCHLORIDE DROPS 7.5 MG. Batch No. EMPC241233 (22500X15 ML)Mfg. Date 03/2 | $16.1K | 2 |
| AMBRODIL DROPS (22500X15ML) AMBROXOL HYD | $16.1K | 2 |
| AMBRODIL SYRUP (16000X100 ML)(AMBROXOL H | $14.9K | 1 |
| Ambrodil Syrup AMBROXOL HYDROCHLORIDE SYRUP 30MG Batch No. EMPM244621 Mfg. Date 12/2024 Exp. Date 05/2027 | $14.8K | 1 |
| AMBRODIL SYRUP (16000X100ML) AMBROXOL HY | $14.2K | 1 |
| HARMLESS MEDICINES: AMBRODIL SYRUP AMBROXOL HYDROCHLORIDE SYRUP 30MG (30000X100ML) | $13.7K | 1 |
Aristo Pharmaceuticals Private Limited exports 77 distinct Ambroxol formulations including tablets, capsules, syrups, and combination drugs. The top formulation is HARMLESS MEDICINES- AMBRODIL SYRUP, AMBROXOL HYDROCHLORIDE S with 2 shipments worth $46.6K.
How Does Aristo Pharmaceuticals Private Limited Compare to Nearest Ambroxol Exporters?
Exporters ranked immediately above and below #9 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 7 | GRACURE PHARMACEUTICALS LIMITED | $470.8K | 19 | 2 | $24.8K |
| 8 | MEDICO REMEDIES LIMITED | $351.1K | 21 | 1 | $16.7K |
| 9 | ARISTO PHARMACEUTICALS PRIVATE LIMITED ★ | $320.1K | 116 | 6 | $2.8K |
| 10 | S K AGE EXPORTS | $301.4K | 25 | 6 | $12.1K |
| 2 | LINCOLN PHARMACEUTICALS LTD | $300.0K | 6 | 4 | $50.0K |
Aristo Pharmaceuticals Private Limited ranks #9 among 296 Indian Ambroxol exporters. Average shipment value of $2.8K compared to the market average of $26.4K. The closest competitors by value are GRACURE PHARMACEUTICALS LIMITED and MEDICO REMEDIES LIMITED.
Which Indian Ports Ship Ambroxol Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 289 | 17.0% |
| JNPT | 116 | 6.8% |
| JNPT/ NHAVA SHEVA SEA | 115 | 6.7% |
| MUNDRA SEA (INMUN1) | 112 | 6.6% |
| SAHAR AIR CARGO ACC (INBOM4) | 109 | 6.4% |
| MUNDRA SEA | 86 | 5.0% |
| SAHAR AIR | 69 | 4.0% |
| AHEMDABAD ICD | 65 | 3.8% |
Geopolitical & Trade Policy Impact on Aristo Pharmaceuticals Private Limited's Ambroxol Exports
The current geopolitical climate presents both challenges and opportunities for Indian pharmaceutical exporters like Aristo Pharmaceuticals. The Israel-Iran tensions have led to disruptions in Red Sea shipping routes, resulting in increased freight costs and extended delivery times. Major shipping lines have implemented 'Emergency Risk Surcharges,' adding financial strain to exporters relying on these routes. Additionally, the U.S. has imposed tariffs on pharmaceutical imports, affecting the profitability of Indian exporters. However, the India–European Union Free Trade Agreement (FTA), concluded in January 2026, offers a silver lining. The FTA eliminates tariffs on Indian pharmaceutical products entering the EU, potentially boosting exports to this region. Aristo Pharmaceuticals can leverage this agreement to strengthen its presence in the European market, offsetting challenges in other regions.
Aristo Pharmaceuticals Private Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for Indian pharmaceutical exporters. The U.S. Food and Drug Administration (FDA), World Health Organization (WHO), and European Union Good Manufacturing Practices (EU GMP) set stringent quality requirements. While specific compliance details for Aristo Pharmaceuticals are not publicly available, adherence to these standards is essential to maintain market access and credibility. The evolving regulatory landscape necessitates continuous investment in quality assurance and compliance infrastructure to meet the expectations of global markets.
About Aristo Pharmaceuticals Private Limited
Aristo Pharmaceuticals Private Limited exports 8 products worth $19.4M. Beyond Ambroxol, top products include Telmisartan, Hydrochlorothiazide, Domperidone, Pioglitazone, Probiotics. View the complete Aristo Pharmaceuticals Private Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Ambroxol — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Ambroxol shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Aristo Pharmaceuticals Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 116 individual customs records matching Aristo Pharmaceuticals Private Limited exporting Ambroxol, covering 77 formulations to 6 countries via 10 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 92+ countries, 486+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Ambroxol Export Data from Aristo Pharmaceuticals Private Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Aristo Pharmaceuticals Private Limited's Ambroxol exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Aristo Pharmaceuticals Private Limited
Full Company Profile →
8 products · $19.4M total trade · 8 categories
Ambroxol Stats
Company Overview
Top Products by Aristo Pharmaceuticals Private Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Aristo Pharmaceuticals Private Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Ambroxol. For current shipment-level data, contact TransData Nexus.